A male infertility medicine is now available for use in men who suffer from male thrushes, according to the Centers for Disease Control and Prevention.
Dr. Thomas N. Bowers, the director of the National Institute of Allergy and Infectious Diseases, told CBS News that the new male thruster pill, known as Sustiva, was developed by a group of researchers who wanted to identify a treatment that could improve the health of men who are sexually frustrated.
Bower said the treatment has shown promise in reducing the symptoms of male thrUSH, the most common male infertility disorder, in men with a diagnosis of male infertility.
“Male thrushes have a lot of symptoms that are quite severe and disabling, so we wanted to understand what it would be like to use male thrusters and see if we could treat them,” Bowers said.
“The answer is, yes.”
The pill works by blocking testosterone production, preventing it from reaching the tissues where it’s needed to control testosterone levels, according the American Association for the Advancement of Science.
It also lowers testosterone levels in the blood, lowering the risk of developing male thrushers.
“These guys are a lot like children, they are constantly getting stimulated and they have to have the energy,” Bower explained.
“So, it is a natural part of their life.
So, to treat them, you want to find something that can help them.”
Bowers added that it is important to make sure that men have a partner who can provide stimulation to their male thrunts.
“That’s really important,” Boulton said.
According to the American College of Obstetricians and Gynecologists, males are less likely to be able to reach orgasm without stimulation.
“It’s the number one cause of sexual dysfunction in men, and it’s one of the main reasons why men are more likely to become sexually inactive and then, eventually, have male infertility,” Bouchard said.
Boulard said the pill will not be approved for men younger than 30, although Bowers hopes that he will be able do more research with men younger.